Cibo Huang

Government of the People's Republic of China - Beijing Hospital

China

SCHOLARLY PAPERS

1

DOWNLOADS

35

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Efficacy and Safety of Mufemilast in Patients with Behçet's Syndrome: A Phase 2, Double-Blind, Placebo-Controlled Trial

Number of pages: 30 Posted: 10 Mar 2025
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Tongji University, Wenzhou Medical University, Xiamen University, Xuzhou Medical University, Xuzhou Medical University, Peking University - Department of Rheumatology and Clinical Immunology, Government of the People's Republic of China - Beijing Hospital, Sun Yat-sen University (SYSU) - Department of Rheumatology, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, Zhejiang University, Zhejiang University, People's Hospital of Xinjiang Uygur Autonomous Region, Shandong University - Linyi People's Hospital, Zhengzhou University - First Affiliated Hospital, Anhui Provincial Hospital, Fudan University - Zhongshan Hospital, Soochow University, Capital Medical University, Jilin Province People’s Hospital, Jilin Province People’s Hospital, The University of Hong Kong - Shenzhen Hospital, Baotou Medical College - First Affiliated Hospital, Fudan University, Fudan University, Nanjing Medical University - Jiangsu Province Hospital, Jilin University, Pingxiang People's Hospital, Hangzhou Medical College - Zhejiang Provincial People's Hospital, Chengdu Medical College, Ganzhou Hemay Pharmaceutical Co., Ltd, Ganzhou Hemay Pharmaceutical Co., Ltd and Peking University - Department of Rheumatology and Immunology
Downloads 35 (1,001,800)

Abstract:

Loading...

Phosphodiesterase 4 inhibitor, Behçet's syndrome, Mufemilast, RCT